Andel

📍 New York, United States🗓 Founded 2025👥 9 employees💰 Last funded Aug 2025
Andel is a revolution in drug affordability — a cooperative employee platform that unlocks access to GLP-1s and other brand name medications. Employees need these medications, but employers can’t afford to cover them. We solve this problem by leveraging the combined buying power of our members to go direct to manufacturers for better prices and a guaranteed supply. Then, employers add a subsidy of their choosing to further reduce costs to members. With true plug-and-play integration, it’s easy to get started at any point in the benefits cycle. Plus, our intuitive digital platform makes tracking costs and managing your benefit simple — while delivering a best-in-class pharmacy experience for members. The Andel Discount Drug Program is not insurance. The Andel Discount Drug Program offers reduced prices from participating providers, and discounts vary by provider and service. Participants are responsible for paying discounted charges, as the Andel Discount Drug Program does not make payments to providers on participants’ behalf. Discounts are available only from providers who have contracted to be in network. For more information and a list of participating providers, please contact us at support@andel.org, or by calling us at (833) 962 6335.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2025
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Andel?
Andel has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Andel last raise funding?
The most recent investment in Andel recorded on gritt.io was in August 2025.
When was Andel founded?
Andel was founded in 2025.
What industry is Andel in?
Andel operates in Public Health. Find similar Public Health investors on gritt.io.
Where is Andel based?
Andel is headquartered in New York, United States.